BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

396 related articles for article (PubMed ID: 24169734)

  • 21. New platinum(II) and palladium(II) complexes with substituted terpyridine ligands: synthesis and characterization, cytotoxicity and reactivity towards biomolecules.
    Savić A; Marzo T; Scaletti F; Massai L; Bartoli G; Hoogenboom R; Messori L; Van Deun R; Van Hecke K
    Biometals; 2019 Feb; 32(1):33-47. PubMed ID: 30367340
    [TBL] [Abstract][Full Text] [Related]  

  • 22. DNA cleavage and antitumour activity of platinum(II) and copper(II) compounds derived from 4-methyl-2-N-(2-pyridylmethyl)aminophenol: spectroscopic, electrochemical and biological investigation.
    Roy S; Maheswari PU; Lutz M; Spek AL; den Dulk H; Barends S; van Wezel GP; Hartl F; Reedijk J
    Dalton Trans; 2009 Dec; (48):10846-60. PubMed ID: 20023915
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Novel C,N-Cyclometalated Benzimidazole Ruthenium(II) and Iridium(III) Complexes as Antitumor and Antiangiogenic Agents: A Structure-Activity Relationship Study.
    Yellol J; Pérez SA; Buceta A; Yellol G; Donaire A; Szumlas P; Bednarski PJ; Makhloufi G; Janiak C; Espinosa A; Ruiz J
    J Med Chem; 2015 Sep; 58(18):7310-27. PubMed ID: 26313136
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pt(II) complexes with (N,N') or (C,N,E)(-) (E=N,S) ligands: cytotoxic studies, effect on DNA tertiary structure and structure-activity relationships.
    Albert J; Bosque R; Crespo M; Granell J; López C; Cortés R; Gonzalez A; Quirante J; Calvis C; Messeguer R; Baldomà L; Badia J; Cascante M
    Bioorg Med Chem; 2013 Jul; 21(14):4210-7. PubMed ID: 23735827
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Novel dinuclear platinum(II) complexes containing mixed nitrogen-sulfur donor ligands.
    Hochreuther S; Puchta R; van Eldik R
    Inorg Chem; 2011 Dec; 50(24):12747-61. PubMed ID: 22085155
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diastereomerically pure platinum(II) complexes as antitumoral agents.: The influence of the mode of binding {(N), (N,O)- or (C,N)}- of (1S,2R)[(η5-C5H5)Fe{(η5-C5H4)CHNCH(Me)CH(OH)C6H5}] and the arrangement of the auxiliary ligands.
    Talancón D; López C; Font-Bardía M; Calvet T; Quirante J; Calvis C; Messeguer R; Cortés R; Cascante M; Baldomà L; Badia J
    J Inorg Biochem; 2013 Jan; 118():1-12. PubMed ID: 23123334
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antiproliferative activity of a series of cisplatin-based Pt(IV)-acetylamido/carboxylato prodrugs.
    Ravera M; Gabano E; Zanellato I; Fregonese F; Pelosi G; Platts JA; Osella D
    Dalton Trans; 2016 Mar; 45(12):5300-9. PubMed ID: 26903367
    [TBL] [Abstract][Full Text] [Related]  

  • 28. New 7-azaindole palladium and platinum complexes: crystal structures and theoretical calculations. In vitro anticancer activity of the platinum compounds.
    Ruiz J; Rodríguez V; de Haro C; Espinosa A; Pérez J; Janiak C
    Dalton Trans; 2010 Apr; 39(13):3290-301. PubMed ID: 20449459
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reactions of a tetranuclear Pt-thiosemicarbazone complex with model proteins.
    Marzo T; Navas F; Cirri D; Merlino A; Ferraro G; Messori L; Quiroga AG
    J Inorg Biochem; 2018 Apr; 181():11-17. PubMed ID: 29353085
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Five-Coordinate Platinum(II) Compounds Containing Sugar Ligands: Synthesis, Characterization, Cytotoxic Activity, and Interaction with Biological Macromolecules.
    Cucciolito ME; D'Amora A; De Feo G; Ferraro G; Giorgio A; Petruk G; Monti DM; Merlino A; Ruffo F
    Inorg Chem; 2018 Mar; 57(6):3133-3143. PubMed ID: 29509011
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Heterometallic platinum(II) compounds with β-aminoethylferrocenes: synthesis, electrochemical behaviour and anticancer activity.
    Nieto D; González-Vadillo AM; Bruña S; Pastor CJ; Ríos-Luci C; León LG; Padrón JM; Navarro-Ranninger C; Cuadrado I
    Dalton Trans; 2012 Jan; 41(2):432-41. PubMed ID: 22025199
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Solution behaviour and biomolecular interactions of two cytotoxic trans-platinum(II) complexes bearing aliphatic amine ligands.
    Cubo L; Casini A; Gabbiani C; Mastrobuoni G; Messori L; Jiménez-Barbero J; Navarro-Ranninger C; Quiroga AG
    Chemistry; 2009 Sep; 15(36):9139-46. PubMed ID: 19655350
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cytotoxic properties of a new organometallic platinum(II) complex and its gold(I) heterobimetallic derivatives.
    Serratrice M; Maiore L; Zucca A; Stoccoro S; Landini I; Mini E; Massai L; Ferraro G; Merlino A; Messori L; Cinellu MA
    Dalton Trans; 2016 Jan; 45(2):579-90. PubMed ID: 26609781
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Replacement of chlorides with dicarboxylate ligands in anticancer active Ru(II)-DMSO compounds: a new strategy that might lead to improved activity.
    Bratsos I; Serli B; Zangrando E; Katsaros N; Alessio E
    Inorg Chem; 2007 Feb; 46(3):975-92. PubMed ID: 17257042
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Novel Nickel(II), Palladium(II), and Platinum(II) Complexes with
    Hildebrandt J; Häfner N; Görls H; Barth MC; Dürst M; Runnebaum IB; Weigand W
    Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35743112
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A novel polynuclear Cu(I)-sulfur cluster with 1,2-dithiolate-o-carborane ligands as a potential in vitro antitumour agent and its DNA binding properties.
    Han Z; Jiang J; Lu J; Li D; Cheng S; Dou J
    Dalton Trans; 2013 Apr; 42(14):4777-80. PubMed ID: 23426331
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Design, synthesis, characterisation and chemical reactivity of mixed-ligand platinum(II) oxadiazoline complexes with potential cytotoxic properties.
    Wagner G; Marchant A; Sayer J
    Dalton Trans; 2010 Sep; 39(33):7747-59. PubMed ID: 20657943
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Crystal structure, electronic properties and cytotoxic activity of palladium chloride complexes with monosubstituted pyridines.
    Krogul A; Cedrowski J; Wiktorska K; Ozimiński WP; Skupińska J; Litwinienko G
    Dalton Trans; 2012 Jan; 41(2):658-66. PubMed ID: 22068915
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anticancer potential of (pentamethylcyclopentadienyl)chloridoiridium(III) complexes bearing κP and κP,κS-coordinated Ph2 PCH2 CH2 CH2 S(O)x Ph (x=0-2) ligands.
    Ludwig G; Ranđelović I; Maksimović-Ivanić D; Mijatović S; Bulatović MZ; Miljković D; Korb M; Lang H; Steinborn D; Kaluđerović GN
    ChemMedChem; 2014 Jul; 9(7):1586-93. PubMed ID: 24470190
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Binucleating Hydrazonic Ligands and Their μ-Hydroxodicopper(II) Complexes as Promising Structural Motifs for Enhanced Antitumor Activity.
    Rada JP; Bastos BSM; Anselmino L; Franco CHJ; Lanznaster M; Diniz R; Fernández CO; Menacho-Márquez M; Percebom AM; Rey NA
    Inorg Chem; 2019 Jul; 58(13):8800-8819. PubMed ID: 31247881
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.